02UL4KZ
Supplement Ventricle, Left to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 2 Heart and Great Vessels |
| Operation | U Supplement |
| Body Part | L Ventricle, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or enhance a portion of the heart or a great vessel without removing the existing structure. Common examples include patch repair of a septal defect, reinforcing a weakened area of the aortic wall, or placing material to strengthen a valve annulus during repair.
The goal is to shore up tissue that is present but insufficient on its own, whether because of a congenital hole, an aneurysm that has thinned the vessel wall, or a valve structure that needs extra support to function properly. Unlike a replacement, the body's own tissue stays in place and the added material works alongside it.
Patients typically encounter this term in the context of congenital defect closures, aortic aneurysm repairs, and valve repair techniques that use patches, rings, or other reinforcing materials rather than swapping out the whole valve or vessel.
Anatomy & Axis Detail
Ventricle, Left
The left ventricle is the heart's primary pumping chamber, generating the pressure needed to drive blood through the systemic circulation, and its thick muscular wall can develop aneurysmal thinning or rupture after transmural myocardial infarction or from ventricular wall trauma. Supplementing the left ventricle involves patching a weakened or thinned segment of the wall, often following infarct-related aneurysm resection or as part of surgical ventricular restoration, using pericardial or synthetic material to reestablish a more physiologic chamber geometry and reduce wall stress. Because the left ventricle bears the highest intracavitary pressures in the heart, the reinforcing material must be robust enough to withstand repeated systolic loading without dehiscence, and surgeons often assess resulting chamber volume and ejection fraction intraoperatively to confirm the repair has not compromised pump function.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign Supplement when the note documents that material, biological or synthetic, was added to reinforce or augment existing anatomy, such as closing a septal defect with a patch or buttressing a vessel wall. The documentation should identify the material used and confirm that native tissue was not removed and replaced, only strengthened.
The most frequent error is confusing patch closure of a defect, which is Supplement, with actual replacement of a structure, which requires taking out the original part. Another common mistake is missing that some valve repairs combine Supplement for annuloplasty ring placement with Repair for other steps done in the same operative session, each of which needs its own code.